Evofem Biosciences, Inc. reports $76.7 million Q1 loss

Evofem Biosciences, Inc. [EVFM] has reported fiscal Q1 loss of $76.70 million.

On a per-share basis, the DE based company said its diluted earnings are $1.34.

The Pharmaceutical Preparations firm posted revenue of $16.70 million in this period.